November 09, 2025

Get In Touch

18F-FCH-PET Has Superior Sensitivity Than Ultrasound Or Sestamibi For Parathyroid Localization: Study

18F-fluorocholine PET for Parathyroid Localization

18F-fluorocholine PET for Parathyroid Localization

The use of 18F-fluorocholine positron emission tomography for parathyroid localization within the first cohort in the United States is better in terms of sensitivity than ultrasound or sestamibi, suggests a study published in the Surgery.

Preoperative parathyroid imaging helps the surgeons during parathyroidectomy. A study conducted by Graves C et al. assesses the clinical influence of 18F-fluorocholine positron emission tomography for preoperative parathyroid localization on patients suffering from primary hyperparathyroidism.

The researchers selected patients with primary hyperparathyroidism and indications for parathyroidectomy had simultaneous 18F-fluorocholine positron emission tomography imaging/magnetic resonance imaging. In patients who underwent subsequent parathyroidectomy, treatment was based on lab values at least 6 months after surgery. Location-based sensitivity and specificity of 18F-fluorocholine positron emission tomography imaging was assessed using 3 anatomic locations (left neck, right neck, and mediastinum), with surgery as the gold standard.

Study Results

  • Among the total 101 patients, 18F-fluorocholine positron emission tomography localized at least 1 candidate lesion in 93% of patients overall and in 91% of patients with previously negative imaging, leading to a change in preoperative strategy in 60% of patients.
  • Of 76 patients who underwent parathyroidectomy, 58 (77%) had laboratory data at least 6 months postoperatively, with 55/58 patients (95%) demonstrating cure.
  • 18F-fluorocholine positron emission tomography successfully guided curative surgery in 48/58 (83%) patients, compared with 20/57 (35%) based on ultrasound and 13/55 (24%) based on sestamibi.
  • In a location-based analysis, the sensitivity of 18F-fluorocholine positron emission tomography (88.9%) outperformed both ultrasound (37.1%) and sestamibi (27.5%), as well as ultrasound and sestamibi combined (47.8%).

The researchers concluded that among the first cohort in the United States, the use of 18F-fluorocholine positron emission tomography for parathyroid localization confirms its utility in a challenging cohort, with better sensitivity than ultrasound or sestamibi.

Reference

Superior sensitivity of 18F-fluorocholine: PET localization in primary hyperparathyroidism by Graves C et al. published in the Surgery.

DOI: https://doi.org/10.1016/j.surg.2021.05.056

Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our Terms of Use, Privacy Policy, and Advertisement Policy.
For further details, please review our Full Disclaimer.

0 Comments

Post a comment

Please login to post a comment.

No comments yet. Be the first to comment!